Christos Kosmas
- Soil Science top 0.5%
- Oncology top 2%
- Cancer Treatment and Pharmacology 40
- Colorectal Cancer Treatments and Studies 32
- Lung Cancer Research Studies 17
- HER2/EGFR in Cancer Research 14
- Earth-Surface Processes top 2%
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 18
- Ecology top 2%
-
- Monoclonal and Polyclonal Antibodies Research 23
-
- Lung Cancer Treatments and Mutations 22
-
- Multiple Myeloma Research and Treatments 15
Christos Kosmas
198 papers receiving 4.9k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Soil Science 1.2k
- Oncology 1.6k
- Earth-Surface Processes 287
- Genetics 340
- Ecology 702
Countries citing papers authored by Christos Kosmas
This map shows the geographic impact of Christos Kosmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christos Kosmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christos Kosmas more than expected).
Fields of papers citing papers by Christos Kosmas
This network shows the impact of papers produced by Christos Kosmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christos Kosmas. The network helps show where Christos Kosmas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christos Kosmas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 24 | |
| 5 | 2020 | 2 | |
| 6 | 2016 | 14 | |
| 7 | 2013 | 11 | |
| 8 | Integration of novel targeted therapies into the systemic treatment of breast cancer--a review. | 2008 | 5 |
| 9 | 2007 | 0 | |
| 10 | 2006 | 3 | |
| 11 | 2005 | 30 | |
| 12 | 2003 | 26 | |
| 13 | 2002 | 12 | |
| 14 | 2002 | 2 | |
| 15 | 2002 | 15 | |
| 16 | 2001 | 32 | |
| 17 | 1998 | 8 | |
| 18 | Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy. | 1992 | 74 |
| 19 | 1989 | 30 | |
| 20 | 1987 | 91 |
About Christos Kosmas
Christos Kosmas is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 207 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (40 papers), Colorectal Cancer Treatments and Studies (32 papers), Monoclonal and Polyclonal Antibodies Research (23 papers), Lung Cancer Treatments and Mutations (22 papers), Chronic Lymphocytic Leukemia Research (18 papers), Lung Cancer Research Studies (17 papers), Multiple Myeloma Research and Treatments (15 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Soil Science (1.2k citations), Oncology (1.6k citations) and Earth-Surface Processes (287 citations). Christos Kosmas has collaborated with scholars based in Greece, United States and United Kingdom. Frequent co-authors include Νicolas Tsavaris, St Gerontidis, Maria Vadiaka, Gérard Govers, Nick B. Tsavaris, N.G. Danalatos, Gregory W. McCarty, Johan Six, J. W. Harden and Timothy A. Quine. Their work appears in journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.